Q3
ADVB — Q3 FY2026 Financial Report Analysis
Pre-revenue Advanced Biomed narrowed its March-quarter loss to $0.49M, mostly on currency, while a $7.35M paper gain from selling its China arm for $23,000 masked going-concern doubt and a pivot from cancer diagnostics to AI.